The overall economic outlook for 2025 may show slow-but-steady growth—”above-potential GDP growth toward 2.2%,” according to EY—but the job forecast is more optimistic for the life sciences sector, ...

Life sciences is standing on the edge of its most consequential decade. Scientific discovery is advancing at breakneck speed—cell and gene therapies, advanced biologics, precision diagnostics—all ...

Addressing analysts earlier this year, executives from Alexandria Real Estate Equities discussed some sobering trends facing biopharma as well as the industry’s enduring strengths, both of which pose ...